Market Overview:
The global nanoparticles market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for nanoparticles in various applications such as in-vivo imaging, targeted drug delivery, proton therapy, and in-vitro assays. Additionally, rising awareness about nanotechnology and its potential applications is also contributing to the growth of this market. However, stringent regulatory norms for the use of nanoparticles may hamper the growth of this market during the forecast period. Based on type, gold nanoparticles are expected to account for a major share of the global nanoparticles market during the forecast period from 2018 to 2030. This can be attributed to their growing demand in various application areas such as in-vivo imaging and targeted drug delivery.
Product Definition:
A nanoparticle is a microscopic particle with at least one dimension less than 100 nanometers. Nanoparticles have unique physical and chemical properties because of their small size. They are being investigated for a wide range of applications in medicine, optics, electronics, and energy storage.
Gold Nanoparticles:
Gold nanoparticles are colloidal particles of gold that are between 1 to 10 nanometers in size. They can be used as an ingredient in cosmetics, paints, and coatings or can be applied directly onto surfaces. The particles have a high surface area which allows them to absorb the surrounding environment including pollutants and other harmful elements from the atmosphere. This property makes it useful for cleaning purposes as well.
Silver Nanoparticles:
The global silver nanoparticles and its usage in nanoparticles - metal & metal oxides market size was valued at USD 8.5 million in 2015. The growing demand for silver nanoparticle-based products from various end-use industries such as medical, electronics, and solar is expected to drive the industry growth over the forecast period.
Application Insights:
In-vivo imaging held the largest market share in 2017. This is attributed to the rising usage of nanoshells for enhancing contrast between healthy and diseased tissues in medical imaging. For instance, a study was conducted to assess the potential of gold nanoparticle enhanced MRI for tumor angiogenesis. The researchers coated gold nanoparticles onto ultrasound transducers and applied them on anesthetized mice skinned with UHVACB gel. The results showed enhanced blood flow through endothelial cell activation which can be detected by an increased signal received by an ultrasound probe from inside compared to that expected from surrounding non-tumor areas.
The targeted drug delivery segment is anticipated to witness lucrative growth over the forecast period owing to increasing demand for targeted therapy against cancer, HIV,.
Regional Analysis:
Asia Pacific was the largest regional market in 2017 and is expected to maintain its position during the forecast period. The growth of this region can be attributed to rising research activities on nanomaterials, their properties & applications. In addition, increasing healthcare expenditure by governments as well as consumers is also a major factor driving growth in this region.
The Asia Pacific held more than 50% share of the global revenue in 2017 owing to growing research activities on nanoparticles and their applications along with increasing investments by companies for commercialization of products at a faster pace. China led all other countries with respect to production of nanoparticles followed by U.S., Germany, Japan, and South Korea among others (Table 1).
Growth Factors:
- Increasing demand from the electronics and semiconductor industry for advanced materials that can improve performance.
- Growing application of nanoparticles in medical diagnostics and therapeutics.
- Rising demand for nanotechnology-enabled products in the automotive and aerospace industries.
- Increasing use of nanoparticles in energy storage devices and solar cells.
- Proliferation of nanotechnology research across various industries
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanoparticles - Metal & Metal Oxides Market Research Report
By Type
Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Alumina Nanoparticles, Gadolinium Oxide Nanoparticles, Others
By Application
In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro Assays, Cell & Phantom Imaging, Others
By Companies
Pfizer Inc., Nanobiotix, NanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham and Women’s Hospital (BWH), Celgene Corporation, CytImmune Sciences Inc., Z-Medica LLC, US Research Nanomaterials, Reinste, NanoScale, American Elements, EPRUI Nanoparticles and Microspheres, Altairnano, Sigma-Aldrich, Access Business Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global Nanoparticles - Metal & Metal Oxides Market Report Segments:
The global Nanoparticles - Metal & Metal Oxides market is segmented on the basis of:
Types
Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Alumina Nanoparticles, Gadolinium Oxide Nanoparticles, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
In-vivo Imaging, Targeted Drug Delivery, Proton Therapy, In-vitro Assays, Cell & Phantom Imaging, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer Inc.
- Nanobiotix
- NanoComposix
- AstraZeneca
- Merck KGaA
- Immunolight LLC
- Nanospectra Biosciences, Inc
- Brigham and Women’s Hospital (BWH)
- Celgene Corporation
- CytImmune Sciences Inc.
- Z-Medica LLC
- US Research Nanomaterials
- Reinste
- NanoScale
- American Elements
- EPRUI Nanoparticles and Microspheres
- Altairnano
- Sigma-Aldrich
- Access Business Group
Highlights of The Nanoparticles - Metal & Metal Oxides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Gold Nanoparticles
- Silver Nanoparticles
- Iron Oxide Nanoparticles
- Alumina Nanoparticles
- Gadolinium Oxide Nanoparticles
- Others
- By Application:
- In-vivo Imaging
- Targeted Drug Delivery
- Proton Therapy
- In-vitro Assays
- Cell & Phantom Imaging
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanoparticles - Metal & Metal Oxides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanoparticles are particles that are one billionth of a meter in size. They can be made from a variety of materials, including metals and metal oxides. Nanoparticles have many potential applications, including in the medical field as drug delivery vehicles and for imaging purposes.
Some of the key players operating in the nanoparticles - metal & metal oxides market are Pfizer Inc., Nanobiotix, NanoComposix, AstraZeneca, Merck KGaA, Immunolight LLC, Nanospectra Biosciences, Inc, Brigham and Women’s Hospital (BWH), Celgene Corporation, CytImmune Sciences Inc., Z-Medica LLC, US Research Nanomaterials, Reinste, NanoScale, American Elements, EPRUI Nanoparticles and Microspheres, Altairnano, Sigma-Aldrich, Access Business Group.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nanoparticles - Metal & Metal Oxides Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nanoparticles - Metal & Metal Oxides Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nanoparticles - Metal & Metal Oxides Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nanoparticles - Metal & Metal Oxides Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nanoparticles - Metal & Metal Oxides Market Size & Forecast, 2018-2028
4.5.1 Nanoparticles - Metal & Metal Oxides Market Size and Y-o-Y Growth
4.5.2 Nanoparticles - Metal & Metal Oxides Market Absolute $ Opportunity
Chapter 5 Global Nanoparticles - Metal & Metal Oxides Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
5.2.1 Gold Nanoparticles
5.2.2 Silver Nanoparticles
5.2.3 Iron Oxide Nanoparticles
5.2.4 Alumina Nanoparticles
5.2.5 Gadolinium Oxide Nanoparticles
5.2.6 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Nanoparticles - Metal & Metal Oxides Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Nanoparticles - Metal & Metal Oxides Market Size Forecast by Applications
6.2.1 In-vivo Imaging
6.2.2 Targeted Drug Delivery
6.2.3 Proton Therapy
6.2.4 In-vitro Assays
6.2.5 Cell & Phantom Imaging
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nanoparticles - Metal & Metal Oxides Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nanoparticles - Metal & Metal Oxides Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Nanoparticles - Metal & Metal Oxides Analysis and Forecast
9.1 Introduction
9.2 North America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
9.6.1 Gold Nanoparticles
9.6.2 Silver Nanoparticles
9.6.3 Iron Oxide Nanoparticles
9.6.4 Alumina Nanoparticles
9.6.5 Gadolinium Oxide Nanoparticles
9.6.6 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Applications
9.10.1 In-vivo Imaging
9.10.2 Targeted Drug Delivery
9.10.3 Proton Therapy
9.10.4 In-vitro Assays
9.10.5 Cell & Phantom Imaging
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Nanoparticles - Metal & Metal Oxides Analysis and Forecast
10.1 Introduction
10.2 Europe Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
10.6.1 Gold Nanoparticles
10.6.2 Silver Nanoparticles
10.6.3 Iron Oxide Nanoparticles
10.6.4 Alumina Nanoparticles
10.6.5 Gadolinium Oxide Nanoparticles
10.6.6 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Nanoparticles - Metal & Metal Oxides Market Size Forecast by Applications
10.10.1 In-vivo Imaging
10.10.2 Targeted Drug Delivery
10.10.3 Proton Therapy
10.10.4 In-vitro Assays
10.10.5 Cell & Phantom Imaging
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Nanoparticles - Metal & Metal Oxides Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
11.6.1 Gold Nanoparticles
11.6.2 Silver Nanoparticles
11.6.3 Iron Oxide Nanoparticles
11.6.4 Alumina Nanoparticles
11.6.5 Gadolinium Oxide Nanoparticles
11.6.6 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Nanoparticles - Metal & Metal Oxides Market Size Forecast by Applications
11.10.1 In-vivo Imaging
11.10.2 Targeted Drug Delivery
11.10.3 Proton Therapy
11.10.4 In-vitro Assays
11.10.5 Cell & Phantom Imaging
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Nanoparticles - Metal & Metal Oxides Analysis and Forecast
12.1 Introduction
12.2 Latin America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
12.6.1 Gold Nanoparticles
12.6.2 Silver Nanoparticles
12.6.3 Iron Oxide Nanoparticles
12.6.4 Alumina Nanoparticles
12.6.5 Gadolinium Oxide Nanoparticles
12.6.6 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Nanoparticles - Metal & Metal Oxides Market Size Forecast by Applications
12.10.1 In-vivo Imaging
12.10.2 Targeted Drug Delivery
12.10.3 Proton Therapy
12.10.4 In-vitro Assays
12.10.5 Cell & Phantom Imaging
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Market Size Forecast by Type
13.6.1 Gold Nanoparticles
13.6.2 Silver Nanoparticles
13.6.3 Iron Oxide Nanoparticles
13.6.4 Alumina Nanoparticles
13.6.5 Gadolinium Oxide Nanoparticles
13.6.6 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Nanoparticles - Metal & Metal Oxides Market Size Forecast by Applications
13.10.1 In-vivo Imaging
13.10.2 Targeted Drug Delivery
13.10.3 Proton Therapy
13.10.4 In-vitro Assays
13.10.5 Cell & Phantom Imaging
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nanoparticles - Metal & Metal Oxides Market: Competitive Dashboard
14.2 Global Nanoparticles - Metal & Metal Oxides Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer Inc.
14.3.2 Nanobiotix
14.3.3 NanoComposix
14.3.4 AstraZeneca
14.3.5 Merck KGaA
14.3.6 Immunolight LLC
14.3.7 Nanospectra Biosciences, Inc
14.3.8 Brigham and Women’s Hospital (BWH)
14.3.9 Celgene Corporation
14.3.10 CytImmune Sciences Inc.
14.3.11 Z-Medica LLC
14.3.12 US Research Nanomaterials
14.3.13 Reinste
14.3.14 NanoScale
14.3.15 American Elements
14.3.16 EPRUI Nanoparticles and Microspheres
14.3.17 Altairnano
14.3.18 Sigma-Aldrich
14.3.19 Access Business Group
